Shuttle Pharmaceuticals Financials - Benzinga

Shuttle Pharmaceuticals Holdings Inc

SHPHNASDAQ

Trade with Public

Trade with Public

$4.58

0.358.27%

At close: Aug 13, 5:00 PM EST

$4.44

-0.14-3.14%

After Hours: 7:02 PM EST

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

Shuttle Pharmaceuticals Financials

Shuttle Pharmaceuticals (SHPH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(0.43) per share. This is a 94.34 percent increase over losses of $(7.60) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q3 EPS $(1.05) Up From $(39.75) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.05) per share. This is a 97.36 percent increase over losses of $(39.75) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q2 EPS $(3.29) Up From $(24.12) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over losses of $(24.12) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.59) per share. This is a 74.73 percent decrease over losses of $(0.91) per share from the same period last year.

Benzinga Newsdesk

US Stocks Mixed; McDonald's Posts Upbeat Earnings

Avi Kapoor